Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Is NF-κB a good target for cancer therapy? Hopes and pitfalls — Véronique Baud (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Shared by
Michael Karin
University of California, San Diego
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Article
2008
en
Related publications
Article
2003
NF-κB in cancer: a marked target
Anning Lin
,
Michael Karin
Chapter in a book
2013
NF-κB and cancer
Willscott E. Naugler
,
Michael Karin
Article
2001
Inhibition of JNK activation through NF-κB target genes
Authors
VB
Véronique Baud
Michael Karin
University of California, San Diego
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Guilin Tang
,
Yuzuru Minemoto
,
Benjamin Dibling
,
Nicole H. Purcell
,
Zhiwei Li
,
Michael Karin
,
Anning Lin
Article
2006
NF‐κB and cancer: Mechanisms and targets
Michael Karin
Article
1997
NF-kB: a pivotal role in asthma and a new target for therapy
Peter J Barnes
,
Ian M. Adcock
Discussion(0)
No comments yet. Be the first to comment.